[go: up one dir, main page]

AU2003239780A1 - Polymorphic forms of a 4h-thieno(3,2-e)-1,2,4-thiadiazine 1,1-dioxide derivative - Google Patents

Polymorphic forms of a 4h-thieno(3,2-e)-1,2,4-thiadiazine 1,1-dioxide derivative

Info

Publication number
AU2003239780A1
AU2003239780A1 AU2003239780A AU2003239780A AU2003239780A1 AU 2003239780 A1 AU2003239780 A1 AU 2003239780A1 AU 2003239780 A AU2003239780 A AU 2003239780A AU 2003239780 A AU2003239780 A AU 2003239780A AU 2003239780 A1 AU2003239780 A1 AU 2003239780A1
Authority
AU
Australia
Prior art keywords
thiadiazine
thieno
polymorphic forms
dioxide derivative
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003239780A
Inventor
Anne Frost Jensen
Claus Ulrich Jessen
Finn Broni Junager
Hanne Tofting Korno
Peter Palitzsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU2003239780A1 publication Critical patent/AU2003239780A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003239780A 2002-07-04 2003-06-24 Polymorphic forms of a 4h-thieno(3,2-e)-1,2,4-thiadiazine 1,1-dioxide derivative Abandoned AU2003239780A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200201047 2002-07-04
DKPA200201047 2002-07-04
PCT/DK2003/000431 WO2004005299A1 (en) 2002-07-04 2003-06-24 Polymorphic forms of a 4h-thieno[3,2-e]-1,2,4-thiadiazine 1,1-dioxide derivative

Publications (1)

Publication Number Publication Date
AU2003239780A1 true AU2003239780A1 (en) 2004-01-23

Family

ID=30011002

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003239780A Abandoned AU2003239780A1 (en) 2002-07-04 2003-06-24 Polymorphic forms of a 4h-thieno(3,2-e)-1,2,4-thiadiazine 1,1-dioxide derivative

Country Status (2)

Country Link
AU (1) AU2003239780A1 (en)
WO (1) WO2004005299A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007077607A1 (en) * 2005-12-28 2007-07-12 Shimadzu Corporation Method of controlling pressure-difference bubble transfer and, making use of the method, gas exchange apparatus, electrical conductivity measuring apparatus, whole organic matter carbon measuring apparatus, reactor and cell culture apparatus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1137125C (en) * 1998-12-18 2004-02-04 诺沃挪第克公司 Fused 1,2,4-thiadiazine derivatives, their preparation and use
AU2001265839A1 (en) * 2000-06-26 2002-01-08 Novo-Nordisk A/S Use of potassium channel agonists for the treatment of cancer
AU2001265841A1 (en) * 2000-06-26 2002-01-08 Novo-Nordisk A/S Use of potassium channel openers for the treatment of insulitis
WO2003045954A1 (en) * 2001-11-30 2003-06-05 Novo Nordisk A/S Use of selective potassium channel openers
AU2002365289A1 (en) * 2001-11-30 2003-06-10 Novo Nordisk A/S Use of selective potassium channel openers

Also Published As

Publication number Publication date
WO2004005299A1 (en) 2004-01-15

Similar Documents

Publication Publication Date Title
TWI347946B (en) 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
AUPS019702A0 (en) Condensed heterocyclic compounds
AU2003214463A1 (en) Releasing mechanism for downhole sealing tool
AU2002228692A1 (en) 3-(2,4-dimethylthiazol-5-yl) indeno(1,2-c)pyrazol-4-one derivatives as cdk inhibitors
AU2003301968A1 (en) 4-aminomethyl-1-aryl-cyclohexylamine derivatives
AU2003264207A1 (en) 1,4-substituted cyclohexane derivatives
AU2003299279A1 (en) Deep hole drill eb90
AUPS022802A0 (en) Anti-viral compounds
AU2003232394A1 (en) Circuit for detecting ground offset of parts of a network
AU2003269949A1 (en) Substituted 1,4-pyrazine derivatives
AU2002358801A1 (en) Drilling tool
AU2003239780A1 (en) Polymorphic forms of a 4h-thieno(3,2-e)-1,2,4-thiadiazine 1,1-dioxide derivative
AU7436400A (en) Bushing for a drilling rig
NO20055002D0 (en) Benzo [1,2,5] thiadiazole
AU2002327276A1 (en) A self-tightening keyless chuck
AU2003301884A1 (en) Methods for making metallocene compounds
AU2003288012A1 (en) Isothiazolyl-benzoxazine derivatives
AU2003205765A1 (en) Siphon for toilets
AU2003258982A1 (en) Methods of inhibiting pin1-associated states using a fredericamycin a compound
AU2002302212A1 (en) A three-jaw tightening chuck
AU2003224149A1 (en) N'-cyano-n-methyl-imidamide derivatives
AU2003207885A1 (en) A toilet
AU2003201028A1 (en) Steering locks
AU2002249279A1 (en) Method for the production of 6-aryl-4h-s-triazolo(3,4-c)-thieno(2,3-e)-1,4-diazepines
AU2003205907A1 (en) Thiazolidine antifungal agents

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase